Literature DB >> 15363646

Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study.

Alison M Elliott1, Wendy S Hodsdon, Jacqueline Kyosiimire, Maria A Quigley, Jessica S Nakiyingi, Proscovia B Namujju, Christine Watera, Neil French, Charles F Gilks, Hazel M Dockrell, James A G Whitworth.   

Abstract

Identifying correlates of immunity or susceptibility to disease promotes understanding of pathogenesis and development of diagnostic tools, treatments, and vaccines. There is evidence that type 1 cytokine responses are associated with protection against tuberculosis, and suppression of type 1, or switching to type 2 responses, with susceptibility, but this has not been studied prospectively. We studied a cohort of 631 HIV-1-infected Ugandan adults. At enrollment we performed whole blood cultures for type 1 (interferon [IFN]-gamma, interleukin [IL]-2) and type 2/immunosuppressive (IL-5, IL-10) responses to mycobacterial antigens (purified protein derivative [PPD] and culture filtrate proteins [CFP]). The incidence of tuberculosis was not associated with IFN-gamma responses, but was higher among participants with IL-2 responses (adjusted rate ratios [RR]: PPD 3.48; CFP 3.99; P < 0.001). For tuberculin skin test-positive participants, high incidence was also associated with an IL-10 response to PPD (adjusted RR 6.24, P = 0.03); for those with a BCG scar, high incidence was associated with positive IL-5 responses (adjusted RRs: PPD 3.64, P = 0.006; CFP 3.44, P = 0.04). The association with IL-2 production may reflect a response to tuberculous infection or to activating disease; the associations with IL-10 and IL-5 are in keeping with the expected role of immunosuppressive or type 2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363646     DOI: 10.1016/j.trstmh.2004.01.007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.

Authors:  Else Marie Agger; Joseph P Cassidy; Joseph Brady; Karen S Korsholm; Carina Vingsbo-Lundberg; Peter Andersen
Journal:  Immunology       Date:  2008-01-12       Impact factor: 7.397

Review 2.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

3.  Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Authors:  Rabia Hussain; Najeeha Talat; Ambreen Ansari; Firdaus Shahid; Zahra Hasan; Ghaffar Dawood
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

Review 4.  The impact of mucosal infections on acquisition and progression of tuberculosis.

Authors:  S Perry; R Hussain; J Parsonnet
Journal:  Mucosal Immunol       Date:  2011-03-16       Impact factor: 7.313

5.  Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.

Authors:  Mecky Matee; Timothy Lahey; Jenni M Vuola; Lillian Mtei; Bernard F Cole; Muhammad Bakari; Robert D Arbeit; C Robert Horsburgh; Kisali Pallangyo; C Fordham von Reyn
Journal:  J Infect Dis       Date:  2006-11-20       Impact factor: 5.226

6.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development.

Authors:  Rabia Hussain; Najeeha Talat; Firdaus Shahid; Ghaffar Dawood
Journal:  Clin Vaccine Immunol       Date:  2007-10-10

8.  Monocyte-derived IL-5 reduces TNF production by Mycobacterium tuberculosis-specific CD4 T cells during SIV/M. tuberculosis coinfection.

Authors:  Collin R Diedrich; Joshua T Mattila; JoAnne L Flynn
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

9.  Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts.

Authors:  Rabia Hussain; Najeeha Talat; Firdaus Shahid; Ghaffar Dawood
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

10.  Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.

Authors:  T Oni; J Patel; H P Gideon; R Seldon; K Wood; Y Hlombe; K A Wilkinson; M X Rangaka; M Mendelson; R J Wilkinson
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.